carmofur has been researched along with Female Genital Neoplasms in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " The average half-life of HCFUf and 5-FUra were 1." | 1.27 | [The determination of thymidylate synthetase inhibition for testing fluoropyrimidines--pharmacokinetics and metabolism of carmofur (HCFU) in patients with gynecologic malignancies--Tokai HCFU Study Group for Gynecologic Malignancies]. ( Hori, M; Kano, T; Mizuno, K; Nishida, Y; Ohta, M; Okamoto, E; Sakakibara, K; Tokuhashi, Y; Tomita, Y; Yoshio, G, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakakibara, K | 1 |
| Mizuno, K | 1 |
| Kano, T | 1 |
| Ohta, M | 1 |
| Tomita, Y | 1 |
| Yoshio, G | 1 |
| Tokuhashi, Y | 1 |
| Nishida, Y | 1 |
| Okamoto, E | 1 |
| Hori, M | 1 |
1 other study available for carmofur and Female Genital Neoplasms
| Article | Year |
|---|---|
[The determination of thymidylate synthetase inhibition for testing fluoropyrimidines--pharmacokinetics and metabolism of carmofur (HCFU) in patients with gynecologic malignancies--Tokai HCFU Study Group for Gynecologic Malignancies].
Topics: Antineoplastic Agents; Female; Floxuridine; Fluorouracil; Genital Neoplasms, Female; Half-Life; Huma | 1986 |